Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation

Hongfei Jiang; Qiuyu Gong; Renshuai Zhang

doi:10.3389/fimmu.2023.1301539

Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation

Front Immunol. 2023 Nov 30:14:1301539. doi: 10.3389/fimmu.2023.1301539. eCollection 2023.

Authors

Hongfei Jiang¹, Qiuyu Gong², Renshuai Zhang¹

Affiliations

¹ The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
² Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

No abstract available

Keywords: anti-inflammatory therapy; biomarker; cancer; inflammation; pyroglutamyl aminopeptidase 1 (PGP-1).

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aminopeptidases* / genetics
Humans
Inflammation / diagnosis
Pyroglutamyl-Peptidase I*

Substances

Pyroglutamyl-Peptidase I
Aminopeptidases

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research received funding supporting from the Natural Science Foundation of Shandong Province (ZR2021QH212) and the Key Research and Development Project of Shaanxi Province (2023-YBSF-292).